Antibody-drug conjugates (ADCs) are a growing class of chemotherapeutic agents for the
purpose of treating cancers that often have relapsed or failed first-and second-line …

Ocular toxicities associated with antibody drug conjugates Page 1 ICU 350601 CURRENT
OPINION Ocular toxicities associated with antibody drug conjugates Rayna F. Marshalla …

Here, we explore whether PEGylation of antibodies can modulate their biodistribution to the
eye, an organ once thought to be immune privileged but has recently been shown to be …

Mice are rarely used in pharmacokinetic (PK) studies of ocular therapeutics due to the small
size of their eyes and challenges in drug administration, tissue collection, and analysis of …